Literature DB >> 34603911

Long noncoding RNA LINC00968 inhibits proliferation, migration and invasion of lung adenocarcinoma through targeting miR-22-5p/CDC14A axis.

Chao Wu1, Xuzhao Bian1, Liyuan Zhang2, Yuanyuan Hu3, Yang Wu1, Tianli Pei1, XinPeng Han2.   

Abstract

Lung adenocarcinoma (LUAD) is a high aggressive human cancer which usually diagnosed at advanced stages. Accumulating evidences indicate that long noncoding RNAs (lncRNAs) are crucial participants in LUAD progression. In the present study, we found that lncRNA LINC00968 was significantly down-regulated in LUAD tissues and cell lines. LINC00968 level was positively correlated to survival rate, and negatively correlated to tumor node metastasis (TNM) stage, tumor size and lymph node metastasis of LUAD patients. We over-expressed LINC00968 in LUAD cells using lentivirus, inhibited proliferation and cell cycle arrest at G1 phase were detected. LINC00968 over-expression also suppressed migration, invasion and epithelial mesenchymal transition. We further validated that LINC00968 localized in cytoplasm and acted as an upstream regulator of microRNA miR-22-5p, which was up-regulated in LUAD tissues and cell lines. Besides, elevated miR-22-5p expression abolished the effect of LINC00968 over-expression on LUAD progression including in vivo tumor growth. In addition, we first validated that cell division cycle 14A (CDC14A), which was down-regulated in LUAD tissues, was a downstream target of miR-22-5p. We over-expressed CDC14A in LUAD cells and miR-22-5p induced LUAD progression was partially reversed. In conclusion, our study demonstrated that LINC00968 inhibited proliferation, migration and invasion of LUAD by sponging miR-22-5p and further restoring CDC14A. This novel regulatory axis might provide us with promising diagnostic and therapeutic target in LUAD treatment. © King Abdulaziz City for Science and Technology 2021.

Entities:  

Keywords:  CDC14A; LINC00968; Lung adenocarcinoma progression; miR-22-5p

Year:  2021        PMID: 34603911      PMCID: PMC8440738          DOI: 10.1007/s13205-021-02981-8

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.893


  37 in total

Review 1.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

2.  Regulatory interactions between long noncoding RNA LINC00968 and miR-9-3p in non-small cell lung cancer: A bioinformatic analysis based on miRNA microarray, GEO and TCGA.

Authors:  Dong-Yao Li; Wen-Jie Chen; Jun Shang; Gang Chen; Shi-Kang Li
Journal:  Oncol Lett       Date:  2018-04-12       Impact factor: 2.967

Review 3.  Long intergenic noncoding RNAs: new links in cancer progression.

Authors:  Miao-Chih Tsai; Robert C Spitale; Howard Y Chang
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

Review 4.  Cell cycle proteins as promising targets in cancer therapy.

Authors:  Tobias Otto; Piotr Sicinski
Journal:  Nat Rev Cancer       Date:  2017-01-27       Impact factor: 60.716

5.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

Review 6.  Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.

Authors:  Julian R Molina; Ping Yang; Stephen D Cassivi; Steven E Schild; Alex A Adjei
Journal:  Mayo Clin Proc       Date:  2008-05       Impact factor: 7.616

Review 7.  Epithelial Mesenchymal Transition in Tumor Metastasis.

Authors:  Vivek Mittal
Journal:  Annu Rev Pathol       Date:  2018-01-24       Impact factor: 23.472

8.  Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.

Authors:  Xianfu Sun; Tao Huang; Chengjuan Zhang; Shengze Zhang; Yingjie Wang; Qiang Zhang; Zhenzhen Liu
Journal:  Cell Cycle       Date:  2019-06-29       Impact factor: 5.173

9.  Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction.

Authors:  Huixian Li; Pengxiang Zhang; Fangjiang Li; Guili Yuan; Xiaoyuan Wang; Aiai Zhang; Feixing Li
Journal:  Biomed Res Int       Date:  2019-04-24       Impact factor: 3.411

10.  LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.

Authors:  Yuxing Zhu; Hao Bo; Zhizhao Chen; Jingjing Li; Dong He; Mengqing Xiao; Liang Xiang; Long Jin; Jianda Zhou; Lian Gong; Yanhong Zhou; Ming Zhou; Wei Xiong; Xiaowei Xing; Ruhong Li; Ke Cao
Journal:  Aging (Albany NY)       Date:  2020-11-04       Impact factor: 5.682

View more
  3 in total

1.  FABP7 inhibits proliferation and invasion abilities of cutaneous squamous cell carcinoma cells via the Notch signaling pathway.

Authors:  Zhonghui Sun; Yunyi Guo; Danlu Zhang; Guolong Zhang; Ying Zhang; Xiuli Wang
Journal:  Oncol Lett       Date:  2022-06-10       Impact factor: 3.111

2.  Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment.

Authors:  Yuanyong Wang; Guofang Lu; Xinying Xue; Mei Xie; Zhaoyang Wang; Zhiqiang Ma; Yingtong Feng; Changjian Shao; Hongtao Duan; Minghong Pan; Peng Ding; Xiaofei Li; Jing Han; Xiaolong Yan
Journal:  Front Immunol       Date:  2022-08-09       Impact factor: 8.786

3.  Identification of a apoptosis-related LncRNA signature to improve prognosis prediction and immunotherapy response in lung adenocarcinoma patients.

Authors:  Ting Luo; Shiqun Yu; Jin Ouyang; Fanfan Zeng; Liyun Gao; Shaoxin Huang; Xin Wang
Journal:  Front Genet       Date:  2022-09-12       Impact factor: 4.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.